(Total Views: 86)
Posted On: 12/06/2023 8:55:46 AM
Post# of 74550

$FBIO News Article - Sentynl Therapeutics Completes Asset Transfer of CUTX-101 Copper Histidinate Product Candidate for Treatment of Menkes Disease from Cyprium Therapeutics https://marketwirenews.com/news-releases/sent...91810.html


My Twitter: WhyteStocks